Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $465.88 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $144.92 | 2 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $110.43 | 1 | $0 (2021) |
| Novo Nordisk Inc | $62.94 | 3 | $0 (2023) |
| ABBVIE INC. | $46.55 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $22.54 | 1 | $0 (2023) |
| Lilly USA, LLC | $19.62 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $15.83 | 1 | $0 (2021) |
| Philips North America LLC | $15.10 | 1 | $0 (2024) |
| Allergan Inc. | $14.69 | 1 | $0 (2018) |
| PFIZER INC. | $13.26 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.32 | 3 | GlaxoSmithKline, LLC. ($20.87) |
| 2023 | $193.79 | 4 | GlaxoSmithKline, LLC. ($124.05) |
| 2022 | $47.97 | 3 | Lilly USA, LLC ($19.62) |
| 2021 | $144.85 | 3 | Janssen Pharmaceuticals, Inc ($110.43) |
| 2018 | $14.69 | 1 | Allergan Inc. ($14.69) |
| 2017 | $13.26 | 1 | PFIZER INC. ($13.26) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: RESPIRATORY | ||||||
| 04/08/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/20/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: Medical Device | ||||||
| 09/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 07/26/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: NEPHROLOGY | ||||||
| 07/25/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.20 | General |
| 07/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $124.05 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 02/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/08/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/08/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,122 | 2,641 | $418,320 | $207,576 |
| 2022 | 20 | 1,033 | 1,867 | $328,092 | $154,985 |
| 2021 | 19 | 971 | 2,385 | $414,481 | $209,219 |
| 2020 | 18 | 1,227 | 3,103 | $504,720 | $253,272 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 131 | 828 | $125,028 | $72,355 | 57.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 429 | $90,070 | $33,399 | 37.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 151 | $44,243 | $18,943 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 141 | 141 | $25,380 | $16,936 | 66.7% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 119 | $17,850 | $11,570 | 64.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 73 | $32,120 | $11,228 | 35.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 111 | $11,655 | $6,416 | 55.1% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 276 | $7,360 | $5,510 | 74.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 50 | $13,000 | $5,399 | 41.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 64 | 88 | $9,328 | $5,230 | 56.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 21 | 26 | $10,400 | $4,970 | 47.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 51 | $10,047 | $4,866 | 48.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 73 | $7,592 | $3,736 | 49.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 140 | 140 | $3,640 | $2,383 | 65.5% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 11 | 11 | $3,487 | $1,560 | 44.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,500 | $1,354 | 30.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 24 | $1,440 | $1,112 | 77.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 13 | 13 | $520.00 | $308.75 | 59.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 20 | 22 | $660.00 | $302.06 | 45.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 108 | 575 | $86,825 | $43,522 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 443 | $93,030 | $38,951 | 41.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 92 | 109 | $31,937 | $15,228 | 47.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 104 | 104 | $18,720 | $12,823 | 68.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 53 | 57 | $15,390 | $7,156 | 46.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 52 | $12,636 | $6,646 | 52.6% |
About Dr. Asif Farooqui, M.D
Dr. Asif Farooqui, M.D is a Internal Medicine healthcare provider based in Highland, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902865421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asif Farooqui, M.D has received a total of $465.88 in payments from pharmaceutical and medical device companies, with $51.32 received in 2024. These payments were reported across 15 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($465.88).
As a Medicare-enrolled provider, Farooqui has provided services to 4,353 Medicare beneficiaries, totaling 9,996 services with total Medicare billing of $825,052. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Highland, IN
- Active Since 03/22/2006
- Last Updated 05/05/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902865421
Products in Payments
- BENLYSTA (Biological) $124.05
- XARELTO (Drug) $110.43
- AVYCAZ (Drug) $30.04
- JYNARQUE (Drug) $22.54
- TRELEGY ELLIPTA (Drug) $20.87
- TRULICITY (Drug) $19.62
- DALVANCE (Drug) $18.59
- FARXIGA (Drug) $15.83
- Rybelsus (Drug) $15.74
- (CK7) Extended Holter (Device) $15.10
- ELIQUIS (Drug) $13.26
- UBRELVY (Drug) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Highland
Dr. Marianne Mann, Md, MD
Internal Medicine — Payments: $2.2M
Mary Tilak, Md, MD
Internal Medicine — Payments: $15,562
Dr. Janet Alvarado, M.d, M.D
Internal Medicine — Payments: $8,938
Dr. Oliver Le, Md, MD
Internal Medicine — Payments: $6,729
Dr. Alejandro Alvarado, M.d, M.D
Internal Medicine — Payments: $6,645
Dr. Brandon Genson, D.o, D.O
Internal Medicine — Payments: $5,812